应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BCRX BioCryst制药
休市中 04-26 16:00:00 EDT
4.16
+0.00
0.00%
盘后
4.16
+0.00
0.00%
18:42 EDT
最高
4.26
最低
4.11
成交量
231.09万
今开
4.21
昨收
4.16
日振幅
3.61%
总市值
8.58亿
流通市值
7.94亿
总股本
2.06亿
成交额
965.65万
换手率
1.21%
流通股本
1.91亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
BUZZ-美国医疗保险公司因 UnitedHealth 第一季度利润增长而上涨
Reuters · 04-16
BUZZ-美国医疗保险公司因 UnitedHealth 第一季度利润增长而上涨
Needham:重申BioCryst Pharma(BCRX.US)评级,由买入调整至买入评级, 目标价12.00美元。
智通财经 · 04-10
Needham:重申BioCryst Pharma(BCRX.US)评级,由买入调整至买入评级, 目标价12.00美元。
BioCryst制药盘中异动 急速下跌5.05%报4.80美元
自选股智能写手 · 04-03
BioCryst制药盘中异动 急速下跌5.05%报4.80美元
BioCryst制药盘中异动 急速下跌5.10%
自选股智能写手 · 03-22
BioCryst制药盘中异动 急速下跌5.10%
BioCryst制药盘中异动 股价大涨5.12%报5.75美元
自选股智能写手 · 03-21
BioCryst制药盘中异动 股价大涨5.12%报5.75美元
BioCryst制药盘中异动 股价大涨5.13%报5.33美元
自选股智能写手 · 03-20
BioCryst制药盘中异动 股价大涨5.13%报5.33美元
BioCryst制药盘中异动 大幅下跌5.06%
自选股智能写手 · 03-15
BioCryst制药盘中异动 大幅下跌5.06%
BioCryst制药2023财年实现净利润-2.27亿美元,同比增加8.10%
自选股智能写手 · 03-02
BioCryst制药2023财年实现净利润-2.27亿美元,同比增加8.10%
加载更多
公司概况
公司名称:
BioCryst制药
所属市场:
NASDAQ
上市日期:
--
主营业务:
BioCryst Pharmaceuticals, Inc.是一家生物技术公司,致力于设计、优化和开发新的药物,新的药物主要是阻止疾病的发病机制的关键酶。该公司是一家始建于1986年的特拉华州公司,该公司专注于治疗领域有未满足的医疗需求,并将其能力与专长联系在一起。公司的利益区域和候选药物的相关开发是由科学发现和潜在的优势,其经验丰富的药物研发组标识,以及这些发现内潜在的商业机会来决定的。该公司通过名为结构导向药物设计过程整合生物学,晶体学,药物化学和计算机模拟等学科,发现和开发小分子药物。
发行价格:
--
{"stockData":{"symbol":"BCRX","market":"US","secType":"STK","nameCN":"BioCryst制药","latestPrice":4.16,"timestamp":1714161600000,"preClose":4.16,"halted":0,"volume":2310942,"hourTrading":{"tag":"盘后","latestPrice":4.16,"preClose":4.16,"latestTime":"18:42 EDT","volume":163937,"amount":682937.62,"timestamp":1714171374026},"delay":0,"floatShares":190880754,"shares":206149929,"eps":-1.178675,"marketStatus":"休市中","marketStatusCode":7,"change":0,"latestTime":"04-26 16:00:00 EDT","open":4.21,"high":4.26,"low":4.11,"amount":9656483.753664,"amplitude":0.036058,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.178675,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714377600000},"adr":0,"listingDate":762670800000,"adjPreClose":4.16,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":4.1973,"preClose":4.16,"latestTime":"08:54 EDT","volume":1004,"amount":4216.857228,"timestamp":1714136095796},"postHourTrading":{"tag":"盘后","latestPrice":4.16,"preClose":4.16,"latestTime":"18:42 EDT","volume":163937,"amount":682937.62,"timestamp":1714171374026},"volumeRatio":0.6201133235914355},"requestUrl":"/m/hq/s/BCRX","defaultTab":"news","newsList":[{"id":"2427982606","title":"BUZZ-美国医疗保险公司因 UnitedHealth 第一季度利润增长而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2427982606","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2427982606?lang=zh_cn&edition=full","pubTime":"2024-04-16 20:25","pubTimestamp":1713270314,"startTime":"0","endTime":"0","summary":" 4月16日 - ** 联合健康集团 公布第一季度财报后,美国医疗保险公司股价在盘前交易中上涨2%至5%。** 尽管其 Change Healthcare 部门 2 月份遭受的网络攻击造成了干扰,但 UNH 仍公布了 乐观的第一季度副利润,并维持 2024 年的业绩预期。** 竞争对手 Humana 上涨 4.6%,CVS Health 上涨 3.8%,Cigna Group 上涨 2.1** 自 11 月下旬以来,医疗保险公司的股价一直承压,当时 UNH 表示,老年人医疗保健的年末增长导致了医疗成本的上升。** 截至目前,HUM 下跌 31.3%,CVS 下跌 12.7%,UNH 下跌 15.4%,而 CI 则上涨 16.5","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2426906464","title":"Needham:重申BioCryst Pharma(BCRX.US)评级,由买入调整至买入评级, 目标价12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2426906464","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2426906464?lang=zh_cn&edition=full","pubTime":"2024-04-10 19:16","pubTimestamp":1712747763,"startTime":"0","endTime":"0","summary":"Needham:重申BioCryst Pharma(BCRX.US)评级,由买入调整至买入评级, 目标价12.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101916068b09cd39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404101916068b09cd39&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424025196","title":"BioCryst制药盘中异动 急速下跌5.05%报4.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424025196","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424025196?lang=zh_cn&edition=full","pubTime":"2024-04-03 00:04","pubTimestamp":1712073843,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日00时04分,BioCryst制药股票出现波动,股价急速跳水5.05%。截至发稿,该股报4.80美元/股,成交量81.5301万股,换手率0.40%,振幅4.26%。BioCryst制药股票所在的生物技术行业中,整体跌幅为1.77%。BioCryst制药公司简介:BioCryst Pharmaceuticals Inc 是一家生物技术公司,主要从事新型小分子药物的研究和开发,以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科,如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404030004047a50ba62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404030004047a50ba62&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421084355","title":"BioCryst制药盘中异动 急速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421084355","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421084355?lang=zh_cn&edition=full","pubTime":"2024-03-22 23:12","pubTimestamp":1711120330,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日23时12分,BioCryst制药股票出现异动,股价快速下挫5.10%。截至发稿,该股报5.21美元/股,成交量51.999万股,换手率0.25%,振幅5.28%。BioCryst制药股票所在的生物技术行业中,整体跌幅为0.13%。BioCryst制药公司简介:BioCryst Pharmaceuticals Inc 是一家生物技术公司,主要从事新型小分子药物的研究和开发,以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科,如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322231210861e0799&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322231210861e0799&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421046979","title":"BioCryst制药盘中异动 股价大涨5.12%报5.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421046979","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421046979?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:39","pubTimestamp":1711028399,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时39分,BioCryst制药股票出现波动,股价大幅上涨5.12%。截至发稿,该股报5.75美元/股,成交量18.4623万股,换手率0.09%,振幅4.94%。BioCryst制药股票所在的生物技术行业中,整体涨幅为0.53%。BioCryst制药公司简介:BioCryst Pharmaceuticals Inc 是一家生物技术公司,主要从事新型小分子药物的研究和开发,以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科,如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212139597a4e40cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403212139597a4e40cf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420300270","title":"BioCryst制药盘中异动 股价大涨5.13%报5.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420300270","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420300270?lang=zh_cn&edition=full","pubTime":"2024-03-20 00:41","pubTimestamp":1710866463,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日00时41分,BioCryst制药股票出现波动,股价快速拉升5.13%。截至发稿,该股报5.33美元/股,成交量89.0784万股,换手率0.43%,振幅5.33%。BioCryst制药股票所在的生物技术行业中,整体跌幅为0.14%。BioCryst制药公司简介:BioCryst Pharmaceuticals Inc 是一家生物技术公司,主要从事新型小分子药物的研究和开发,以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科,如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320004103861df759&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320004103861df759&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419980645","title":"BioCryst制药盘中异动 大幅下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419980645","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419980645?lang=zh_cn&edition=full","pubTime":"2024-03-15 01:05","pubTimestamp":1710435937,"startTime":"0","endTime":"0","summary":"北京时间2024年03月15日01时05分,BioCryst制药股票出现波动,股价急速跳水5.06%。截至发稿,该股报4.88美元/股,成交量125.492万股,换手率0.61%,振幅4.09%。BioCryst制药股票所在的生物技术行业中,整体跌幅为0.59%。BioCryst制药公司简介:BioCryst Pharmaceuticals Inc 是一家生物技术公司,主要从事新型小分子药物的研究和开发,以阻断感染和炎症疾病的关键酶。Biocryst的研究基于多种科学学科,如生物学、计算机建模和药物化学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031501053787e78fe0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031501053787e78fe0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416623131","title":"BioCryst制药2023财年实现净利润-2.27亿美元,同比增加8.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416623131","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416623131?lang=zh_cn&edition=full","pubTime":"2024-03-02 00:22","pubTimestamp":1709310166,"startTime":"0","endTime":"0","summary":"12月31日,BioCryst制药公布财报,公告显示公司2023财年净利润为-2.27亿美元,同比增加8.10%;其中营业收入为3.31亿美元,同比增加22.14%,每股基本收益为-1.18美元。从资产负债表来看,BioCryst制药总负债9.72亿美元,其中短期债务26.21百万美元,资产负债比为0.54,流动比率为3.31。机构评级:截至2023年12月31日,当前有10家机构对BioCryst制药目标价做出预测,其中目标均价为14.20美元,其中最低目标价为6.00美元,最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030200225887d85b15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030200225887d85b15&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biocryst.com","stockEarnings":[{"period":"1week","weight":-0.0609},{"period":"1month","weight":-0.1922},{"period":"3month","weight":-0.2353},{"period":"6month","weight":-0.2166},{"period":"1year","weight":-0.4475},{"period":"ytd","weight":-0.3055}],"compareEarnings":[{"period":"1week","weight":0.0265},{"period":"1month","weight":-0.0285},{"period":"3month","weight":0.0428},{"period":"6month","weight":0.2376},{"period":"1year","weight":0.2324},{"period":"ytd","weight":0.0693}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BioCryst Pharmaceuticals, Inc.是一家生物技术公司,致力于设计、优化和开发新的药物,新的药物主要是阻止疾病的发病机制的关键酶。该公司是一家始建于1986年的特拉华州公司,该公司专注于治疗领域有未满足的医疗需求,并将其能力与专长联系在一起。公司的利益区域和候选药物的相关开发是由科学发现和潜在的优势,其经验丰富的药物研发组标识,以及这些发现内潜在的商业机会来决定的。该公司通过名为结构导向药物设计过程整合生物学,晶体学,药物化学和计算机模拟等学科,发现和开发小分子药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.566667,"avgChangeRate":0.030527},{"month":2,"riseRate":0.5,"avgChangeRate":-0.014169},{"month":3,"riseRate":0.366667,"avgChangeRate":0.019768},{"month":4,"riseRate":0.548387,"avgChangeRate":0.044855},{"month":5,"riseRate":0.533333,"avgChangeRate":0.04118},{"month":6,"riseRate":0.633333,"avgChangeRate":0.036002},{"month":7,"riseRate":0.566667,"avgChangeRate":0.117871},{"month":8,"riseRate":0.566667,"avgChangeRate":0.099165},{"month":9,"riseRate":0.366667,"avgChangeRate":-0.045723},{"month":10,"riseRate":0.5,"avgChangeRate":-0.050698},{"month":11,"riseRate":0.5,"avgChangeRate":0.042837},{"month":12,"riseRate":0.466667,"avgChangeRate":0.002044}],"exchange":"NASDAQ","name":"BioCryst制药","nameEN":"Biocryst Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioCryst制药(BCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioCryst制药(BCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioCryst制药,BCRX,BioCryst制药股票,BioCryst制药股票老虎,BioCryst制药股票老虎国际,BioCryst制药行情,BioCryst制药股票行情,BioCryst制药股价,BioCryst制药股市,BioCryst制药股票价格,BioCryst制药股票交易,BioCryst制药股票购买,BioCryst制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioCryst制药(BCRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioCryst制药(BCRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}